Top compounds associated with response to CPVL


Feature Type Standardized
Nominal ANOVA
mRNA lapatinib GDSC1000 pan-cancer AAC -0.11 0.03
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.074 0.04
mRNA paclitaxel CTRPv2 pan-cancer AAC -0.07 0.04
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC -0.062 0.04
mRNA AZD0530 FIMM pan-cancer AAC -0.38 0.04
mRNA BRD-K71781559 CTRPv2 pan-cancer AAC 0.08 0.04
mRNA BRD8899 CTRPv2 pan-cancer AAC 0.079 0.04
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.075 0.04
mRNA YM201636 GDSC1000 pan-cancer AAC 0.066 0.04
mRNA MI-2 CTRPv2 pan-cancer AAC 0.11 0.04
Download CSV